Werewolf Therapeutics Inc...

NASDAQ: HOWL · Real-Time Price · USD
1.33
0.01 (0.76%)
At close: Aug 15, 2025, 3:59 PM
1.35
1.50%
After-hours: Aug 15, 2025, 05:47 PM EDT

Werewolf Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-73.14M -72.41M -70.52M -62.12M -53.73M -41.58M -37.37M -37.3M -40.95M -50.45M -53.81M -59.75M -61.56M -57.89M -49.98M -39.52M -31.83M -18.65M
Depreciation & Amortization
1.73M 1.78M 1.81M 1.83M 1.82M 1.8M 1.76M 1.72M 1.68M 1.43M 1.1M 735K 398K 275K 216K 212K 186K 166K
Stock-Based Compensation
7.72M 8.53M 8.83M 8.79M 8.88M 8.21M 8.01M 8.08M 7.92M 7.76M 7.4M 6.75M 6.3M 5.3M 4.09M 3.02M 1.67M 1.11M
Other Working Capital
293K -1.83M -2.28M 2.37M -930K -6.79M -7.75M -15.24M -16.49M 2.17M 3.42M 9.46M 14.84M 2.47M 1.27M -571K -1.08M 667K
Other Non-Cash Items
-1.5M -2.69M 638K 3.15M 6.9M 7.88M 6.8M 4.19M 745K 1.18M 2.17M 1.53M 1.41M 736K 519K 827K 1M 991K
Deferred Income Tax
n/a n/a n/a -2.81M -5.92M -5.92M -5.92M -3.11M n/a n/a n/a n/a n/a n/a n/a n/a n/a -7.3M
Change in Working Capital
4.37M 4.96M 3.05M 4.63M 787K -8.4M -5.89M -13.48M -16.55M 3.54M 2.54M 9.33M 14.12M 2.08M 2.28M -755K 595K 1.48M
Operating Cash Flow
-60.83M -59.84M -56.19M -46.52M -41.27M -38.01M -32.61M -39.9M -47.16M -36.54M -40.6M -41.4M -39.34M -49.5M -42.88M -36.21M -28.72M -22.55M
Capital Expenditures
-126K -143K -254K -329K -547K -712K -769K -1.09M -2.82M -3.75M -3.61M -3.37M -1.51M -513K -498K -235K -190K -124K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Investing Cash Flow
-126K -143K -254K -329K -547K -712K -769K -1.09M -2.82M -3.75M -3.61M -3.37M -1.51M -513K -498K -235K -190K -124K
Debt Repayment
10M n/a n/a -10M -10M n/a 40M 40M 40M 40M n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
14.05M 13.07M 13.08M -371K -535K 112K 100K -265K -156K -444K -285K -73K -317K 110.12M 109.43M 109.2M 109.38M 21.25M
Financial Cash Flow
2.93M -7.18M 13.08M 19.61M 19.65M 30.07M 58.43M 50.61M 61.65M 64.37M 15.91M 14.69M 3.34M 110.12M 109.43M 181.27M 181.45M 93.32M
Net Cash Flow
-58.02M -47.13M -23.34M -7.44M -2.15M -8.67M 25.04M 9.83M 11.66M 24.08M -28.3M -30.08M -37.52M 60.11M 66.05M 144.82M 152.54M 70.64M
Free Cash Flow
-60.95M -59.98M -56.44M -46.85M -41.81M -38.72M -33.38M -40.99M -49.98M -40.29M -44.21M -44.76M -40.86M -50.01M -43.37M -36.45M -28.91M -22.68M